AMBROSE KRISTEN (SVP & Chief Accounting Officer) sold 12.0% of their position (1.38K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $633.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0000875320-26-000036
Officer· SVP & Chief Accounting Officer
Since May 2021
-1.97K
Net shares
Net seller
$910.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
1.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−592.00
Price / share
$468.41
Trade value
$277.30K
% of position
4.9%
2/10/2026
12.10K→11.50K
Common Stock
Direct
Shares
−1.38K
Price / share
$460.43
Trade value
$633.55K
% of position
12.0%
2/11/2026
11.50K→10.13K
Total
Net shares
−1.97K
Net value
-$910.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −592.00 | $468.41 | $277.30K | 4.9% | 12.10K | 11.50K |
| Common Stock Direct | 2/11/2026 | S · Sale | −1.38K | $460.43 | $633.55K | 12.0% | 11.50K | 10.13K |
| Total | −1.97K | -$910.85K | ||||||
Derivative Transactions0
No derivative transactions reported